NextCell Pharma: We’re in Flemingsberg because of the proximity to collaborative partners and the clinical research at Karolinska University Hospital.
At the forefront of medical innovation, NextCell Pharma is poised to revolutionize treatment paradigms. With a dual focus on developing therapies for autoimmune conditions and offering stem cell banking through Cellaviva, CEO Mathias Svahn leads the charge towards a future where incurable diseases become a thing of the past.
What is your business idea, what problem do you want to solve?
“Nextcell Pharma is a research and development company with two different business areas. One where we develop new treatments for autoimmune and inflammatory conditions. It’s here that our primary focus lies, Diabetes Type 1 that works as a model disease for us to later expand its use,” says Mathias Svahn, NextCell Pharma CEO.
“Our other business area is Cellaviva which offer expectant parents to save their children’s stem cells at birth, in a so-called family bank. The primary reason to save stem cells in a family bank is the possibility to take advantage of future new therapies and treatments.”
Where are you now?
“We’re now conducting a clinical drug trial of our drug candidate ProTrans. Something we do together with Karolinska Trial Alliance at Karolinska University Hospital here in Flemingsberg,” says Svahn.
“The aim is to demonstrate that the treatment is safe and discover whether patients’ own insulin production can be improved following a 12-month ProTrans-stem cell treatment.”
What are your plans for the future?
“Our goal is to develop new types of treatment for illnesses that we have not achieved previously, conditions that are currently incurable. Since last year, NextCell Pharma has been listed on Aktietorget to support our chances of reaching that goal,” says Svahn.
“At the same time, we want to offer many more families the opportunity to save their children’s stem cells at birth. We have recently signed an agreement with Nordic Tech House and Isabella Löwengrip to reach more parents to tell them about this opportunity.
Why are you in Flemingsberg?
“Flemingsberg is entirely the right place for us due to its closeness to co-operation partners and the clinical research at Karolinska University Hospital. Furthermore, this is the right place for us to grow given how Flemingsberg as a whole is flourishing and developing,” says Svahn.
Contact
Karolinska Science Park
Hälsovägen 7
141 57 Huddinge
08-735 55 95
Hitchhiker’s Guide to Startup Success: Mastering the Art of the Perfect Pitch
Earlier this fall, we launched the first event in our seminar series, Hitchhiker’s Guide to Startup Success, which we are organizing together with Miltenyi Biotec. The inaugural session featured an inspiring workshop led by pitch expert and coach Malcolm Larri. The event gathered innovators and entrepreneurs in the Life Sciences sector, with a particular focus on Advanced Therapy Medicinal Products (ATMP)—a rapidly growing field with tremendous potential to revolutionize healthcare.
Key2Compliance Becomes a Trusted Partner in Strategic Collaboration to Advance ATMP and Life Science Development in Flemingsberg
Key2Compliance has become a Trusted Partner to Flemingsberg Science Foundation, a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.
AWA Becomes a Trusted Partner in Strategic Collaboration to Advance ATMP and Life Science Development in Flemingsberg
AWA has become a Trusted Partner to Flemingsberg Science Foundation, a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.
Flemingsberg’s Role in Advancing Life Science in Southern Stockholm
During Almedalen week this year, we had the opportunity to delve into Flemingsberg’s significance for southern Stockholm as a world-leading player in life science. The purpose of the roundtable discussion was to raise awareness about Flemingsberg’s development in life science and create a platform for the exchange of experiences. We shared valuable insights on how Flemingsberg can become one of Sweden’s most significant centers for education, research, and creativity.
